TY - JOUR
T1 - Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients
T2 - Disease expression, microbial aetiology, and clinical outcomes
AU - Abdominal Sepsis Study (AbSeS) group for the Trials Group of the European Society of Intensive Care Medicine
AU - Paiva, José-Artur
AU - Rello, Jordi
AU - Eckmann, Christian
AU - Antonelli, Massimo
AU - Arvaniti, Kostoula
AU - Koulenti, Despoina
AU - Papathanakos, Georgios
AU - Dimopoulos, George
AU - Deschepper, Mieke
AU - Blot, Stijn
AU - Pinilla, Darío
N1 - Copyright © 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Publisher Copyright:
© 2024 European Federation of Internal Medicine
PY - 2024
Y1 - 2024
N2 - We compared epidemiology of intra-abdominal infection (IAI) between immunocompromised and non-immunocompromised ICU patients and identified risk factors for mortality. We performed a secondary analysis on the "AbSeS" database, a prospective, observational study with IAI patients from 309 ICUs in 42 countries. Immunocompromised status was defined as either neutropenia or prolonged corticosteroids use, chemotherapy or radiotherapy in the past year, bone marrow or solid organ transplantation, congenital immunodeficiency, or immunosuppressive drugs use. Mortality was defined as ICU mortality at any time or 28-day mortality for those discharged earlier. Associations with mortality were assessed by logistic regression. The cohort included 2589 patients of which 239 immunocompromised (9.2 %), most with secondary peritonitis. Among immunocompromised patients, biliary tract infections were less frequent, typhlitis more frequent, and IAIs were more frequently healthcare-associated or early-onset hospital-acquired compared with immunocompetent patients. No difference existed in grade of anatomical disruption, disease severity, organ failure, pathogens, and resistance patterns. Septic shock was significantly more frequent in the immunocompromised population. Mortality was similar in both groups (31.1% vs. 28.9 %; p = 0.468). Immunocompromise was not a risk factor for mortality (OR 0.98, 95 % CI 0.66-1.43). Independent risk factors for mortality among immunocompromised patients included septic shock at presentation (OR 6.64, 95 % CI 1.27-55.72), and unsuccessful source control with persistent inflammation (OR 5.48, 95 % CI 2.29-12.57). In immunocompromised ICU patients with IAI, short-term mortality was similar to immunocompetent patients, despite the former presented more frequently with septic shock, and septic shock and persistent inflammation after source control were independent risk factors for death.
AB - We compared epidemiology of intra-abdominal infection (IAI) between immunocompromised and non-immunocompromised ICU patients and identified risk factors for mortality. We performed a secondary analysis on the "AbSeS" database, a prospective, observational study with IAI patients from 309 ICUs in 42 countries. Immunocompromised status was defined as either neutropenia or prolonged corticosteroids use, chemotherapy or radiotherapy in the past year, bone marrow or solid organ transplantation, congenital immunodeficiency, or immunosuppressive drugs use. Mortality was defined as ICU mortality at any time or 28-day mortality for those discharged earlier. Associations with mortality were assessed by logistic regression. The cohort included 2589 patients of which 239 immunocompromised (9.2 %), most with secondary peritonitis. Among immunocompromised patients, biliary tract infections were less frequent, typhlitis more frequent, and IAIs were more frequently healthcare-associated or early-onset hospital-acquired compared with immunocompetent patients. No difference existed in grade of anatomical disruption, disease severity, organ failure, pathogens, and resistance patterns. Septic shock was significantly more frequent in the immunocompromised population. Mortality was similar in both groups (31.1% vs. 28.9 %; p = 0.468). Immunocompromise was not a risk factor for mortality (OR 0.98, 95 % CI 0.66-1.43). Independent risk factors for mortality among immunocompromised patients included septic shock at presentation (OR 6.64, 95 % CI 1.27-55.72), and unsuccessful source control with persistent inflammation (OR 5.48, 95 % CI 2.29-12.57). In immunocompromised ICU patients with IAI, short-term mortality was similar to immunocompetent patients, despite the former presented more frequently with septic shock, and septic shock and persistent inflammation after source control were independent risk factors for death.
KW - Intra-abdominal infection
KW - Immunocompromised
KW - Intensive care unit
KW - Immunocompromised
KW - Intensive care unit
KW - Intra-abdominal infection
KW - Mortality
KW - Peritonitis
KW - Sepsis
UR - http://www.scopus.com/inward/record.url?scp=85200147054&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/85e907fa-7570-3d2c-b6ba-88eccddd09a4/
U2 - 10.1016/j.ejim.2024.07.019
DO - 10.1016/j.ejim.2024.07.019
M3 - Artículo
C2 - 39079800
SN - 0953-6205
JO - European journal of internal medicine
JF - European journal of internal medicine
ER -